Remedy Meds Without Insurance: Cash-Pay GLP-1 Costs Explained

Last reviewed: September 19, 2026 Last updated: September 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Remedy Meds publishes no prices publicly—figures appear only after you complete an intake questionnaire. The one checkout-verified plan we captured in July 2026 was a microdose option at $189/month, month-to-month, with unlimited clinician visits and phone support included. Secondary evidence from a Forbes review suggests standard semaglutide may cost $299/month and tirzepatide $399/month, but we did not see those plans at checkout and Remedy's intake gates its pricing behind contact forms. By contrast, PlexusDx publishes all cash-pay rates on product pages: $129/month for the Microdose GLP-1 Protocol, $189 for semaglutide injection, and $289 for tirzepatide injection, all month-to-month with no membership. If you want transparent pricing and the lowest verified microdose rate, PlexusDx wins on paper. If you value Remedy's results warranty and bundled care model and are comfortable confirming price at checkout, request a quote through its intake.

At-a-glance comparison

Normalized 12-month cash-pay costs

Remedy Meds shows no prices publicly, so we completed its intake questionnaire to capture checkout pricing. On July 20, 2026, the one plan Remedy's funnel offered was a microdose option at $189/month. We did not see standard-dose semaglutide or tirzepatide plans at checkout; secondary evidence from a Forbes review suggests those may cost $299 and $399 per month respectively, but we cannot verify those figures from Remedy's own checkout. PlexusDx publishes all pricing on product pages. The comparisons below use month-to-month rates for apples-to-apples analysis; both providers offer cancel-anytime terms.

Microdose GLP-1 (verified checkout pricing)

• PlexusDx Microdose GLP-1 Protocol: $129/month × 12 = $1,548/year
• Remedy Meds microdose plan: $189/month × 12 = $2,268/year (checkout-verified July 20, 2026)
• Annual difference: PlexusDx is $720 lower over 12 months, or $60 lower per month (our calculation).

Standard-dose semaglutide injection (secondary evidence—confirm at checkout)

• PlexusDx: $189/month × 12 = $2,268/year
• Remedy Meds: $299/month × 12 = $3,588/year (secondary evidence from Forbes review captured Sept 4, 2026; intake verification did not reveal this plan)
• Annual difference: PlexusDx is $1,320 lower over 12 months, or $110 lower per month, if the $299 figure is accurate (our calculation).

Standard-dose tirzepatide injection (secondary evidence—confirm at checkout)

• PlexusDx: $289/month × 12 = $3,468/year
• Remedy Meds: $399/month × 12 = $4,788/year (secondary evidence from Forbes review captured Sept 4, 2026; intake verification did not reveal this plan)
• Annual difference: PlexusDx is $1,320 lower over 12 months, or $110 lower per month, if the $399 figure is accurate (our calculation).

Important: Remedy's standard-dose pricing comes from secondary sources and could not be confirmed at checkout. The only plan we saw when completing Remedy's intake in July 2026 was the $189 microdose option. If you are considering standard-dose semaglutide or tirzepatide from Remedy, complete its intake to confirm the current cash-pay rate before enrolling.

Where the advertised $9.99/day rate fits

Remedy Meds advertises "start today for just $9.99/day" on its primary marketing page (captured Sept 4, 2026). Multiply that daily rate by 30.3 days per average month and you get roughly $302.70 per month—close to the secondary-evidence $299 standard semaglutide figure. However, Remedy does not itemize which product the $9.99/day teaser refers to, and when we completed intake in July 2026 the only plan shown was the $189/month microdose option, which would imply a daily rate of about $6.24 (our calculation). We cannot reconcile the advertised $9.99/day with the checkout-verified $189/month microdose figure. If you see the $9.99/day rate, ask Remedy's team which plan and dose it applies to before assuming it matches your intended protocol.

What each plan includes

Both Remedy Meds and PlexusDx bundle medication, clinician oversight, and shipping into the monthly rate with no separate membership fee.

Remedy Meds includes compounded medication, unlimited clinician video visits, always-on phone support, a U.S.-based care team, and shipping. The company ships every 28 days on a month-to-month basis and offers a "guaranteed or it's free" results warranty (we captured the pledge but not its full terms; contact Remedy for conditions). All plans are cancel-anytime.

PlexusDx includes compounded medication, an online provider consult, prescription review and approval, and shipping. Month-to-month plans ship every 30 days; 3-month and 6-month prepaid plans unlock lower per-month rates ($149/month prepaid equivalent for microdose on the 6-month plan, $169 on 3-month; our calculation). PlexusDx also offers an optional gene-medication response test—$298 standalone or $99 for program members—with a free check-in with a Doctor of Pharmacy to discuss the results. The test does not select a medication; a licensed provider determines your prescription based on clinical factors.

Price transparency and the intake-gate trade-off

The sharpest difference between these two providers is how—and when—you learn the price.

Remedy Meds publishes no prices on its website. Every source we reviewed confirmed the same pattern: you see a figure only after completing an intake questionnaire that asks for email, phone, and health history. During our July 2026 verification the intake reached an "approved plan" contact gate; we cleared the email and phone inputs and the page showed the $189 microdose plan before completing enrollment. Secondary sources (a Forbes review captured Sept 4, 2026) cite $299 for standard semaglutide and $399 for tirzepatide, but we did not encounter those plans at checkout. If you need to budget before starting an intake or want to compare cash-pay rates across multiple providers, Remedy's model requires an extra step.

PlexusDx publishes all pricing on product pages: $129/month for the microdose protocol, $189 for semaglutide injection, $289 for tirzepatide injection, and $289 for oral semaglutide, every figure in month-to-month terms with 3-month and 6-month prepaid discounts shown alongside. You see the full cost structure before you start intake, and the price does not change by dose tier—starter, intermediate, and maintenance doses all cost the same monthly rate within each product line.

Neither approach is inherently better; the trade-off is immediacy versus personalized quoting. If you value seeing a published rate before sharing contact information, PlexusDx's product pages deliver that. If you prefer a care model that tailors the plan recommendation after reviewing your intake, Remedy's gated pricing may feel more concierge-style—though you will not know the cost until you reach the contact gate.

Remedy's results warranty and care model

Remedy Meds offers a "guaranteed or it's free" results warranty, a feature PlexusDx does not match. We captured the pledge during checkout verification on July 20, 2026, but did not see the full terms or conditions; contact Remedy's support team to understand what qualifies for a refund or credit and what timeline applies. If a money-back safety net influences your decision to start GLP-1 therapy, this is a point in Remedy's favor.

Remedy also emphasizes unlimited clinician video visits and always-on phone support with a U.S.-based care team, which may appeal if you expect frequent check-ins or have questions outside standard messaging hours. PlexusDx includes provider messaging and consult access within the monthly rate but does not advertise "unlimited video visits" as a headline feature. If high-touch clinical support is a priority and you are comfortable with Remedy's intake-gated pricing, that care model may justify the higher microdose cost.

Choose Remedy Meds if…

• You want a results warranty and are willing to confirm terms before enrolling.
• Unlimited video visits and always-on phone support matter more to you than lowest monthly cost.
• You prefer a provider that tailors the plan recommendation after reviewing your intake, even if that means seeing the price later in the funnel.
• You are comfortable with the $189/month microdose rate (verified) or are willing to confirm standard-dose pricing at checkout (secondary evidence suggests $299 semaglutide, $399 tirzepatide—but verify before committing).

Choose PlexusDx if…

• You want the lowest verified cash-pay microdose rate: $129/month versus Remedy's $189 (saves $60/month, $720/year; our calculation).
• You want transparent, published pricing before you start intake—no contact gate, no questionnaire required to see the cost.
• You want one flat rate that does not change by dose tier: starter, intermediate, and maintenance doses all cost the same within each product line.
• You value the option to add gene-medication response testing ($99 for members) with a Doctor of Pharmacy check-in, even though the test does not dictate medication choice.
• You prefer a straightforward month-to-month plan with the option to prepay 3 or 6 months for lower effective rates (microdose drops to $109/month on the 6-month plan—our calculation from the prepaid total).

Methodology and freshness

We verified Remedy Meds pricing by completing its intake questionnaire on July 20, 2026, reaching the approved-plan contact gate and capturing the $189/month microdose plan offer. We also reviewed Remedy's primary marketing page and a Forbes review (both captured Sept 4, 2026) that cited $299 for semaglutide and $399 for tirzepatide; we classify those figures as secondary evidence because we did not see them at checkout and Remedy publishes no prices publicly. PlexusDx pricing was captured from published product pages in July 2026. Trustpilot ratings were verified on September 9, 2026 (PlexusDx) and displayed during Remedy's intake on September 4, 2026. All 12-month cost totals and savings calculations are our own work, derived by multiplying the stated monthly rates by 12. Remedy's standard-dose pricing remains secondary evidence and should be confirmed at checkout before enrolling. All figures in this article reflect month-to-month, cancel-anytime terms unless otherwise noted; prepaid plan costs are labeled as such and are our calculation from the stated prepaid totals.

Frequently Asked Questions

Does Remedy Meds publish its cash-pay GLP-1 prices publicly?

No. Every source we reviewed—including our own intake verification—confirmed that Remedy shows pricing only after you complete an intake questionnaire. The one plan we saw at checkout in July 2026 was a microdose option at $189/month. Secondary sources cite higher rates for standard doses, but those figures could not be verified at checkout.

How does Remedy's $189 microdose plan compare to PlexusDx's microdose protocol?

PlexusDx's Microdose GLP-1 Protocol costs $129/month month-to-month, $60 per month lower than Remedy's verified $189/month microdose plan. Over 12 months that difference totals $720 (our calculation). Both plans are cancel-anytime with medication, clinician oversight, and shipping included.

What does Remedy Meds' results warranty cover?

Remedy advertises a "guaranteed or it's free" results warranty. We captured the pledge during checkout verification but not the full terms. Contact Remedy's support team before enrolling to understand what qualifies for a refund or credit, what timeline applies, and any conditions that must be met.

Are the $299 semaglutide and $399 tirzepatide rates for Remedy accurate?

Those figures come from a Forbes review captured September 4, 2026, and we classify them as secondary evidence. Our own intake verification in July 2026 showed only the $189 microdose plan; we did not see standard-dose semaglutide or tirzepatide at checkout. Confirm the current cash-pay rate for your intended dose by completing Remedy's intake before committing.

Do both providers charge a membership fee on top of the monthly medication cost?

No. Both Remedy Meds and PlexusDx bundle medication, clinician oversight, and shipping into the monthly rate with no separate membership fee. Remedy's $189 microdose plan and PlexusDx's $129 microdose protocol are all-inclusive, month-to-month, cancel-anytime prices with no hidden recurring fees.

Sources

• PlexusDx and Remedy Meds product pages and intake funnels (verified July 20, 2026)
• Remedy Meds primary marketing page (captured September 4, 2026)
• Forbes review of Remedy Meds (captured September 4, 2026)
• Trustpilot.com/review/plexusdx.com (verified September 9, 2026)
• Remedy Meds Trustpilot rating displayed during intake (captured September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.